Medica Group PLC Director/PDMR Shareholding (7379C)
22 June 2021 - 10:45PM
UK Regulatory
TIDMMGP
RNS Number : 7379C
Medica Group PLC
22 June 2021
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 22 June 2021,
the PDMRs listed below were granted options over ordinary shares of
0.2p each in the Company under the Company's Performance Share Plan
2017 at a nil exercise price:
Name of PDMR Number of shares subject to
option
Stuart Quin 106,535
Richard Jones 75,201
Kevin Terrins 46,535
Sarah Burns 46,535
Marc O'Brien 56,401
Caroline Byrne 26,984
Rob Lavis 51,654
The notifications set out below are provided in accordance with
the requirements of the UK Market Abuse Regulation, and set out
more details of the transactions.
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
-------------------------- -----------------------------------------------
2. Reason for notification
---------------------------------------------------------------------------
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Business Development Director
4. Chief Operating Officer
5. Chief Technical Officer
6. Managing Director, Ireland
7. Medical Director
-------------------------- -----------------------------------------------
Initial notification Initial notification in each case
/ amendment
-------------------------- -----------------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------
(a) Name Medica Group PLC
-------------------------- -----------------------------------------------
(b) LEI 213800B8XE5FUSZF5Z16
-------------------------- -----------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
have been conducted
---------------------------------------------------------------------------
(a) Description of Ordinary shares of 0.2p each in the
the financial instrument capital of the Company ("Shares")
-------------------------- -----------------------------------------------
(b) Nature of the transaction Grant of options to acquire Shares
pursuant to the Company's Performance
Share Plan 2017
-------------------------- -----------------------------------------------
(c) Price(s) and volume Option Price nil in each case
1. 106,535
2. 75,201
3. 46,535
4. 46,535
5. 56,401
6. 26,984
7. 51,654
-------------------------- -----------------------------------------------
(d) Aggregated information N/A
-------------------------- -----------------------------------------------
(e) Date of the transaction 22 June 2021
-------------------------- -----------------------------------------------
(f) Place of the transaction Outside a trading venue
-------------------------- -----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHDKBBQBBKDNAB
(END) Dow Jones Newswires
June 22, 2021 08:45 ET (12:45 GMT)
Medica (LSE:MGP)
Historical Stock Chart
From Mar 2024 to May 2024
Medica (LSE:MGP)
Historical Stock Chart
From May 2023 to May 2024